Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS)
International Journal of Molecular Sciences · 10.10.2025 · 26 (20) · 9872
DOI: 10.3390/ijms26209872 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.10.2025. Verfasst von Minoo Sharbafshaaer und 7 weiteren Autor:innen. Beteiligte Einrichtung: First Division of Neurology and Neurophysiopathology, AOU Università degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, NF-E2-Related Factor 2, Antioxidants. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder involving the progressive degeneration of upper and lower motor neurons. While oxidative stress, RNA-binding protein (RBP) pathology, mitochondrial dysfunction, and glial–neuronal dysregulation is involved in ALS pathogenesis, current therapies provide limited benefit, underscoring the need for multi-target disease-modifying strategies. Nuclear factor erythroid 2-related factor 2 (Nrf2), classically regarded as a master regulator of redox homeostasis, has recently emerged as a central integrator of cellular stress responses relevant to ALS. Beyond its canonical antioxidant function, Nrf2 regulates critical pathways involved in mitochondrial quality control, proteostasis, nucleocytoplasmic transport, RNA surveillance, and glial reactivity. Experimental models demonstrate that astrocyte-specific Nrf2 activation enhances glutathione metabolism, suppresses neuroinflammation, promotes stress granule disassembly, and reduces RBP aggregation. In C9orf72-linked ALS, Nrf2 activation mitigates dipeptide repeat protein toxicity and restores RNA processing fidelity via modulation of nonsense-mediated decay and R-loop resolution. Recent advances in Nrf2-targeted interventions including Keap1–Nrf2 protein–protein interaction inhibitors, dual Nrf2/HSF1 activators, and cell-type-selective Adeno-associated virus 9 (AAV9) vectors show promise in preclinical ALS models. These multimodal approaches highlight Nrf2’s therapeutic versatility and potential to address the upstream convergence points of ALS pathogenesis. Taken together, positioning Nrf2 as a systems-level regulator offers a novel framework for developing precision-based therapies in ALS. Integrating Nrf2 activation with RNA- and glia-directed strategies may enable comprehensive modulation of disease progression at its molecular roots.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Division of Neurology and Neurophysiopathology, AOU Università degli Studi della Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
- CNR-IBBR National Research Council, Institute of Biosciences and Bioresources, 80131 Naples, Italy.
ORCID-Profile: Minoo Sharbafshaaer, Rosaria Notariale, Paolo Bergamo, Francesca Trojsi
Zitieren
APA
Sharbafshaaer, M., Pepe, R., Notariale, R., Canale, F., Tedeschi, G., Tessitore, A., Bergamo, P., & Trojsi, F. (2025). Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS). International Journal of Molecular Sciences, 26(20), 9872. https://doi.org/10.3390/ijms26209872
Vancouver
Sharbafshaaer M, Pepe R, Notariale R, Canale F, Tedeschi G, Tessitore A, et al. Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS). International Journal of Molecular Sciences. 2025;26(20):9872. doi:10.3390/ijms26209872
BibTeX
@article{Sharbafshaaer2025,
author = {Sharbafshaaer, Minoo and Pepe, Roberta and Notariale, Rosaria and Canale, Fabrizio and Tedeschi, Gioacchino and Tessitore, Alessandro and Bergamo, Paolo and Trojsi, Francesca},
title = {Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS)},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {20},
pages = {9872},
doi = {10.3390/ijms26209872}
}
EUVIMED